Introduction
Promoters for RNA polymerase II transcription are composed of core and regulatory regions. The general transcription factors (GTFs), which are essential for constructing an active transcription initiation complex in conjunction with an RNA polymerase, bind to the core regions. On the other hand, positive regulatory transcription factors (activators) bind to the regulatory regions that consist of proper combinations of cisregulatory elements, accomplishing transcription regulation under precise temporal and spatial control. Recent studies have revealed that another class of transcription factors termed coactivators or mediators play a crucial role by interacting with both a variety of activators and components of GTFs, tethering these two classes of transcription factors (Lewin 1990; Kornberg 1996) . Some coactivators have been shown to bind to multiple activators and interconnect plural signaling pathways at their crossings, leading to the activations of gene transcriptions by GTFs (Janknecht & Hunter 1996; Torchia et al. 1998) .
The coactivators, multiprotein bridging f actor 1 and 2 (MBF1 and MBF2), have been identified as non-DNA binding factors necessary for transcriptional activation of fushi tarazu (ftz) gene by orphan nuclear receptor FTZ-F1 in a cell-free extract of the silkworm Bombyx mori (Li et al. 1994) . In in vitro transcription studies, it is suggested that the coactivator MBF1 recruits TBP to a promoter carrying the FTZ-F1-binding site by interacting with both FTZ-F1 and TATA box-binding protein (TBP), and stabilizes the FTZ-F1 binding to DNA (Li et al. 1994) . It also binds to MBF2, another coactivator, which activates transcription through its contact with TFIIA (Li et al. 1997; Takemaru et al. 1997) . The sequence of MBF1 is highly conserved across species from yeast to human, indicating its importance. Among them, yeast MBF1 has been shown to mediate GCN4-dependent transcriptional activation by bridging GCN4 and TBP (Takemaru et al. 1998) .
While most celebrated coactivators interact with activation domains of activators, some interact with their DNA-binding domains (Wagner & Green 1994; Ptashne & Gann 1997) . The Bombyx mori MBF1 binds to a DNA binding region of FTZ-F1, called FTZ-F1 box, and its yeast counterpart binds to the DNA binding basic region of the bZIP domain of GCN4 (Ueda et al. 1992; Li et al. 1994; Takemaru et al. 1997; Takemaru et al. 1998) . The binding of MBF1 to FTZ-F1 or GCN4 stimulates their bindings to the target DNA sequences in a similar manner as the human T-cell leukaemia virus transactivator Tax does (Baranger et al. 1995; Perini et al. 1995) . In this study, we identified the well-structured core domain of MBF1 which is capable of binding to TBP, and determined its secondary structure by NMR. The N-terminal region indispensable for the binding to the activator was found to be flexible in solution. By the combination with a previous mutation analysis, it is suggested that one of four amphipathic helices of MBF1 serve as a binding site to TBP.
Results

Identification of the core domain of MBF1
MBF1 was expressed efficiently from cDNA in bacterial cells, and recovered in a soluble fraction after lysis of the harvested cells. The recombinant MBF1 was purified chromatographically as described in Experimental procedures, and its final purity was more than 95% as judged by 15% SDS-polyacrylamide gel electrophoresis (PAGE). Finally 15 mg of the protein was obtained from a 2 L culture. H) HSQC spectra of the native MBF1(A) and its ϳ9 kDa fragment purified from the ␣-chymotrypsindigested mixture of MBF1 (see text) (B). Spectra were recorded at 310 K and pH 6.5, using WATERGATE and water-flip-back for suppression of water signal.
resolved peaks were observed in addition to severely overlapping signals in the spectral region, 8.0-8.5 p.p.m. for 1 H and 119-124 p.p.m. for 15 N, in which backbone signals of amide groups in random coil conformation are usually observed. This observation suggests that MBF1 has both flexible and well-structured parts in solution, and the latter consists of about 80 amino acid residues. Because of the low pH (6.5) of the sample solution and the employment of the water-flip-back technique for the water suppression, the reduced number of the resolved cross peaks is not likely mainly due to the exchange of amide protons with solvent water and/or saturation transfer effects from water. In gel-filtration chromatography, MBF1 was eluted at smaller retention volumes than expected from its molecular weight, further suggesting that MBF1 has a disordered part that makes the effective radius of the protein larger than that expected from a compact structure (data not shown).
In order to identify the structured part of the protein, we performed limited proteolysis of MBF1 with ␣-chymotrypsin. MBF1 was incubated with the proteinase at various enzyme/substrate (E/S) ratios at room temperature for 3 h, and the digested mixture was analyzed by 17.5% SDS-PAGE (Fig. 2) . Several sizes of ␣-chymotrypsin-resistant fragments appeared. Among them, the peptide whose apparent mol. wt of ϳ9 kDa was relatively resistant to the proteinase digestion, and remained in the digested mixture at higher E/S ratios, such as 1/20. To identify the region for the 9 kDa fragment in the sequence of MBF1, it was purified from the digested mixture at the E/S ratio of 1/10, followed by the analysis of N-terminal amino acid sequence. The result showed that N-terminal sequence of the 9 kDa fragment is the 67th and the following residues of native MBF1 (Fig. 3) . Analysis using mass spectroscopy showed that the molecular weight of the fragment is 9111, indicating that it comprises residues 67-146 of Bombyx mori MBF1, MBF1 . severely overlapping peaks observed in the random coil region of the spectrum of the full-length MBF1 were totally removed by the proteinase digestion. These observations indicate that MBF1 consists of the Cterminal structured domain (residues 67-146; MBF1 CTD ) and the N-terminal flexible region (residues 1-66). We also recorded the HSQC spectrum of the 55-146th residues of native MBF1 (not shown), finding no further resolved signals that originate from residues 55-66. Residues in MBF1 CTD are highly conserved across the sequences of MBF1s (Fig. 3) . values observed for residues 126-139, except for 132-133, were comparable to those observed for helical regions, despite of the absence of regular secondary structure in this region. This observation suggest that residues 126-139 might form a structured loop.
Sequential assignments of MBF1 CTD
Discussion
Domain organization of MBF1
In the present study, the combined use of NMR measurements, limited proteolysis, N-terminal sequencing and mass spectroscopy revealed that the C-terminal 80 residues of MBF1, are well structured, forming a structurally independent domain, MBF1 CTD . Takemaru et al. (1997) have reported that the fragment consisting of residues 67-146 is capable of binding to TBP, and the binding activity is comparable to that of the full-length MBF1, while it failed to bind to either FTZ-F1 or MBF2. This indicates that MBF1 CTD corresponds to the TBP binding domain of MBF1. In contrast to the C-terminal residues, the 66 N-terminal residues do not form a single definite structure based on the poor dispersion of the cross peaks in the ( 15 N, 1 H) HSQC and the high sensitivity for the proteinase. Comparing the spectra of the intact MBF1 with that of MBF1 CTD (Fig. 1A,B) , it is clear that all cross peaks attributed to the backbone of these N-terminus of the intact MBF1, except for one at 130.5 p.p.m. for case of the native MBF1, it is unlikely that there is a stable interaction between MBF1 CTD and the Nterminal residues in the intact MBF1. Thus, it remains an open question why the deletion of the N-terminal 34 residues from the native Bombyx mori MBF1 results in its enhanced binding to TBP (Takemaru et al. 1997) . In contrast, deletion of the N-terminal 40 residues of yeast MBF1 exert small impact for its binding to TBP (Takemaru et al. 1998 ).
Structure and function of MBF1 CTD
The combined analyses, using chemical shift indices of backbone nuclei, medium-and short-range NOE connectivities, backbone vicinal coupling constants ( 3 J ␣N ) and exchange rates of backbone amide protons with solvent, revealed that MBF1 CTD contains four ␣ helices. Helical wheel representation shows that these helices exhibit typically amphipathic character (Fig. 6 ). These hydrophobic residues are almost completely conserved across the sequences of MBF1s as shown in Fig. 3 , suggesting that the foldings are essentially identical across MBF1s from other species.
In addition to the residues in the four helices, the C-terminal region, residues 126-133, are well conserved in the MBF1 sequences (88-100% amino acid similarity), containing basic and hydrophobic residues, Ile 126, Lys 129, Leu 130, Arg 131 and Lys 133 which are almost identical across the MBF1 sequences. The heteronuclear 15 N{ 1 H}-NOE values observed for these residues suggest that this C-terminal region might be a part of a well-structured core domain. The structural importance of the region was demonstrated by a deletion analysis, which showed that removal of the C-terminal 18 residues resulted in the total loss of the tertiary structure of MBF1 CTD , as judged from its ( 15 N, 1 H) HSQC spectrum (data not shown), further indicating that the C-terminal residues are part of the structural domain, which contribute to the maintenance of the folding.
The C-terminal domain of Bombyx mori MBF1 is capable of binding to TBP by itself. In a similar manner the peptide containing the C-terminal 80 residues of human MBF1, residues 69-148, is able to bind to TBP as strongly as the full-length human MBF1 does consequent loss of in vivo activity: Yeast cells harbouring this mutant were sensitive to aminotriazole, an inhibitor of the HIS3 gene product (Takemaru et al. 1998) . Acidic residue is completely conserved at this position across the MBF1 sequences from species, suggesting that the negatively charged sidechain at this position is crucial for the TBP binding. The corresponding residue in Bombyx mori MBF1, Asp 106, is located at the hydrophilic face of the amphipathic helix 3, suggesting that this residue is exposed to the protein surface and thus not structurally vital (Fig. 6) . This is further supported by the observation that the yeast MBF1-D112A mutant protein is as stable as the native protein (Takemaru et al. 1998 ). The exposed side of this third helix also contains another conserved acidic residue, Glu 108. The interaction between MBF1 and TBP, as monitored by GST pull-down and gel shift assays, is highly sensitive to ionic strength (Takemaru et al. 1997; Takemaru et al. 1998) , suggesting that Asp 106 and/or Glu108 might electrostatically interact with TBP. Residues in the helix 3 are well conserved across the MBF1 family (86-100%), further suggesting the functional importance of the helix.
The N-terminal residues
The present analyses suggest that the 66 N-terminal residues does not form a single definite structure, based on the poor dispersion of the ( 15 N, 1 H) cross peaks and the sensitivity for the proteinase digestion. As deletion of these residues causes loss of the binding of MBF1 to FTZ-F1 and MBF2, it is suggested that the N-terminal part serves as a binding site for FTZ-F1 and MBF2. Since the interaction between MBF1 and FTZ-F1 is rather stable, it is implied that the N-terminal residues undergo folding transitions when they encounters the activator. Induced folding from otherwise unfolded states is often encountered in protein-protein interactions between transcriptional factors: the activation domain of p53 by binding to MDM2 (Kussie et al. 1996) , the activation domain of VP16 by binding to hTAF II 31 (Uesugi et al. 1997) , KIX domain by binding to CBP (Radhakrishnan et al. 1997) , and the transcriptional inhibitory domain of dTAF II 230 by binding to TBP (Liu et al. 1998) . MBF1 is characterized by its ability to bind several different transcriptional factors, for instance: human MBF1 can bind to either Ad4BP, ATF1, CREB1 or CREBP1 (Y. Kabe, M. Goto, D. Shima, T. Wada, K. Morohashi, M. Shirakawa, S. Hirose & H. Handa, unpublished result). The structural flexibility and plasticity of the N-terminal residues may provide a mechanism for MBF1 to adopt different conformations at different binding activators, giving ability of multiple bindings. Lefstin & Yamamoto (1998) proposed that the allosteric effects of DNA on transcriptional regulators play crucial roles in protein-protein interactions, providing the examples that show the importance of the flexibility and plasticity in transcriptional factors.
The binding of MBF1 to FTZ-F1 or GCN4 significantly increases the stability of the DNA affinity of these activators. A similar phenomenon has been observed for Tax in the association with the bZIP element of ATF family proteins that bind the CRE target site (Baranger et al. 1995; Perini et al. 1995) . For the Tax case, it interacts with the basic region of bZIP, and not only stabilizes the dimerization of the DNA binding proteins, but also increase the stability of the protein-DNA complex. It is thought that Tax stabilizes the helical structure of the activators suitable for the DNA binding, lowering the entropy loss upon its complexation with DNA. Interestingly, the MBF1 target site of FTZ-F1, FTZ-F1 box, is similar to the basic region of the bZIP element (Ueda et al. 1992) . However, while bZIP proteins whose DNA bindings are affected by the presence of Tax bind to their target sites as dimers, it is thought that one of the targets of MBF1, FTZ-F1, binds to DNA as a monomer, suggesting that the mechanism of the stimulated binding caused by MBF1 may be different from that by Tax. MBF1 does not have apparent sequence similarity with Tax.
Our data now provide the structural features of MBF1: it has flexible N-terminal residues that are responsible for its multiple binding to activators, and a well-structured C-terminal domain that is responsible for binding to a unique general transcription factor, TBP. This may be one of typical features for coactivators that function by 'integration' or 'rectification' of multiple inputs from activators to produce a integrated output to GTFs (Wagner & Green 1994; Bray 1995; Janknecht & Hunter 1996) .
Experimental procedures
Protein expression and purification
To produce Bombyx mori MBF1, a T7-expression system was used. Plasmid pET-MBF1 was introduced into Escherichia coli BL21(DE3) cells. The transformed bacteria were cultured at 37 ЊC and then induced with 2 mM IPTG for 4 h. H-triple labeling. The frozen cell paste was suspended in 15 mL of buffer A (50 mM Tris-HCl, pH 7.7, 400 mM KCl, 1 mM DTT and 1 mM PMSF), followed by sonication on ice. Insoluble materials were removed by centrifugation at 40 000 g for 30 min at 4 ЊC. To remove DNA, the supernatant was put on to a DEAE-Sepharose (Pharmacia) column which had been equilibrated with buffer A. The flowthrough fraction was dialyzed against 2 L of buffer B (50 mM phosphate, pH 6.8, 50 mM KCl and 1 mM DTT) for 4 h at 4 ЊC. The dialysate was applied on to an SP-Sepharose (Pharmacia) column which had been equilibrated with buffer B. The protein was eluted with a linear gradient of 50 mM-1 M KCl in buffer B. MBF1 was eluted in the 200-300 mM KCl fraction, and then the fractions were dialyzed against 1 L buffer B. The dialysate was put on to a Mono-S (Pharmacia) column, and the concentrated protein solution was eluted by a KCl gradient. If necessary, Hiload 26/60 Sephacryl S-100 gel filtration (Pharmacia) was performed. The purity was checked by 15% SDS-PAGE stained with Coomassie Brilliant Blue.
Limited proteolysis of MBF1 with ␣-chymotrypsin
Domain mapping of MBF1 by means of limited proteolysis was performed by the method of Uegaki et al. (1993) . ␣-chymotrypsin was purchased from Sigma, USA. The mixtures of MBF1 and ␣-chymotrypsin were dissolved in 15 L of the buffer (50 mM Tris-HCl, pH 8.0, 1 mM EDTA, 7 mM 2-mercaptoethanol and 10% glycerol) for 3 h at room temperature in various enzyme/substrate ratios: 1/20, 1/40, 1/80, 1/160, 1/320, 1/640, 1/1280, 1/2560 and 1/5120. The results were analyzed by 17.5% SDS-PAGE.
15
N-labeled MBF1 was digested by the enzyme with a ratio of 1/10 for 3 h at room temperature. The mixture of MBF1 and enzyme was then put on to a SP-sepharose column which had been equilibrated with buffer B. The column was immediately washed with buffer B to remove enzyme. The digested MBF1 was eluted with 1 M KCl in buffer B.
N-terminal sequencing
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